Hypothalamic control of lipid metabolism: Focus on leptin, ghrelin and melanocortins

Neuroendocrinology

Volumn 94, Issue 1, 2011, Pages 1-11

  Diéguez, Carlos ^a,b   Vazquez, María J ^a,b   Romero, Amparo ^a,b   López, Miguel ^a,b   Nogueiras, Ruben ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

AMP activated protein kinase; Hypothalamus; Sympathetic nervous system

Indexed keywords

GHRELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MELANOCORTIN;

ADRENERGIC SYSTEM; ARTICLE; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID METABOLISM; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ENERGY METABOLISM; FEEDING BEHAVIOR; GHRELIN; HUMANS; HYPOTHALAMUS; LEPTIN; LIPID METABOLISM; MELANOCORTINS;

EID: 79960932903     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000328122     Document Type: Article

References (82)

1. Flier JS: Obesity wars: Molecular progress confronts an expanding epidemic. Cell 2004; 116: 337-350. (Pubitemid 38167322)
2. van den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D: Orexigen-sensitive NPY/ AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 2004; 7: 493-494. (Pubitemid 38544585)
3. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168. (Pubitemid 27034218)
4. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-484. (Pubitemid 32494394)
5. Qiu J, Fang Y, Ronnekleiv OK, Kelly MJ: Leptin excites proopiomelanocortin neurons via activation of TRPC channels. J Neurosci 2010; 30: 1560-1565.
6. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198. (Pubitemid 32144284)
7. Bamshad M, Aoki VT, Adkison MG, Warren WS, Bartness TJ: Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol 1998; 275:R291-R299.
8. Bamshad M, Song CK, Bartness TJ: CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 1999; 276:R1569-R1578. (Pubitemid 29323518)
9. Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, Van Heijningen CL, Sluiter AA, Mettenleiter TC, Romijn JA, Sauerwein HP, Buijs RM: Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 2002; 110: 1243-1250. (Pubitemid 35285750)
10. Kreier F, Kap YS, Mettenleiter TC, van Heijningen C, van der Vliet J, Kalsbeek A, Sauerwein HP, Fliers E, Romijn JA, Buijs RM: Tracing from fat tissue, liver, and pancreas: A neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 2006; 147: 1140-1147. (Pubitemid 43244345)
11. Nogueiras R, Lopez M, Dieguez C: Regulation of lipid metabolism by energy availability: A role for the central nervous system. Obes Rev 2010; 11: 185-201.
12. Lage R, Dieguez C, Vidal-Puig A, Lopez M: AMPK: A metabolic gauge regulating wholebody energy homeostasis. Trends Mol Med 2008; 14: 539-549.
13. Hu Z, Cha SH, Chohnan S, Lane MD: Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci USA 2003; 100: 12624-12629. (Pubitemid 37339949)
14. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP: Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288: 2379-2381. (Pubitemid 30448165)
15. Lopez M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vazquez MJ, Finer N, Powles TJ, O'Rahilly S, Saha AK, Dieguez C, Vidal-Puig AJ: Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 2006; 55: 1327-1336. (Pubitemid 44195371)
16. Lopez M, Lage R, Saha AK, Perez-Tilve D, Vazquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodriguez-Cuenca S, Deoliveira RM, Castaneda T, Datta R, Dong JZ, Culler M, Sleeman MW, Alvarez CV, Gallego R, Lelliott CJ, Carling D, Tschop MH, Dieguez C, Vidal-Puig A: Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008; 7: 389-399. (Pubitemid 351618114)
17. Poplawski MM, Mastaitis JW, Yang XJ, Mobbs CV: Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology; 151: 5206-5217.
18. Chakravarthy MV, Zhu Y, Lopez M, Yin L, Wozniak DF, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD, Semenkovich CF: Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. J Clin Invest 2007; 117: 2539-2552. (Pubitemid 47494355)
19. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-574. (Pubitemid 38480541)
20. Obici S, Feng Z, Arduini A, Conti R, Rossetti L: Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003; 9: 756-761. (Pubitemid 36749226)
21. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, Rossetti L: Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 2006; 116: 1081-1091.
22. Wolfgang MJ, Kurama T, Dai Y, Suwa A, Asaumi M, Matsumoto S, Cha SH, Shimokawa T, Lane MD: The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA 2006; 103: 7282-7287. (Pubitemid 43727824)
23. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL, Ladenheim EE, Ronnett GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH: Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci USA 2007; 104: 17358-17363. (Pubitemid 350219847)
24. Lopez M, Varela L, Vazquez MJ, Rodriguez- Cuenca S, Gonzalez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Martinez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni K, Dieguez C, Vidal-Puig A: Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 2010; 16: 1001-1008.
25. Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD: Differential effects of central fructose and glucose on hypothalamic malonyl- CoA and food intake. Proc Natl Acad Sci USA 2008; 105: 16871-16875.
26. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS: Potential role for AMPactivated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 2004; 53: 1953-1958. (Pubitemid 38970741)
27. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU: Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004; 10: 727-733. (Pubitemid 38937638)
28. Stoppa GR, Cesquini M, Roman EA, Prada PO, Torsoni AS, Romanatto T, Saad MJ, Velloso LA, Torsoni MA: Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling. J Endocrinol 2008; 198: 157-168. (Pubitemid 352038195)
29. Cha SH, Lane MD: Central lactate metabolism suppresses food intake via the hypothalamic amp kinase/malonyl-CoA signaling pathway. Biochem Biophys Res Commun 2009; 386: 212-216.
30. Lam TK, Schwartz GJ, Rossetti L: Hypothalamic sensing of fatty acids. Nat Neurosci 2005; 8: 579-584. (Pubitemid 40594197)
31. Frederich RC, Lollmann B, Hamann A, Napolitano- Rosen A, Kahn BB, Lowell BB, Flier JS: Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995; 96: 1658-1663.
32. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. (Pubitemid 24365442)
33. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner- Jeanrenaud F, Burger AG, Zapf J, Meier CA: Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100: 2858-2864. (Pubitemid 28007556)
34. Fruhbeck G, Aguado M, Martinez JA: In vitro lipolytic effect of leptin on mouse adipocytes: Evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 1997; 240: 590-594. (Pubitemid 28271762)
35. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ: Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389: 374-377. (Pubitemid 27415217)
36. Fruhbeck G, Aguado M, Gomez-Ambrosi J, Martinez JA: Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ ob mice, but not db/db mice. Biochem Biophys Res Commun 1998; 250: 99-102. (Pubitemid 28448630)
37. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey- White J, Schwartz GJ, Kunos G, Rossetti L: Leptin controls adipose tissue lipogene - sis via central, STAT3-independent mechanisms. Nat Med 2008; 14: 667-675. (Pubitemid 351809549)
38. Lin J, Choi YH, Hartzell DL, Li C, Della-Fera MA, Baile CA: CNS melanocortin and lep - tin effects on stearoyl-CoA desaturase-1 and resistin expression. Biochem Biophys Res Commun 2003; 311: 324-328. (Pubitemid 37340080)
39. Gallardo N, Bonzon-Kulichenko E, Fernandez- Agullo T, Molto E, Gomez-Alonso S, Blanco P, Carrascosa JM, Ros M, Andres A: Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 2007; 148: 5604-5610. (Pubitemid 350146140)
40. Tajima D, Masaki T, Hidaka S, Kakuma T, Sakata T, Yoshimatsu H: Acute central infusion of leptin modulates fatty acid mobilization by affecting lipolysis and mRNA expression for uncoupling proteins. Exp Biol Med (Maywood) 2005; 230: 200-206. (Pubitemid 40293693)
41. Prieur X, Tung YC, Griffin JL, Farooqi IS, O'Rahilly S, Coll AP: Leptin regulates peripheral lipid metabolism primarily through central effects on food intake. Endocrinology 2008; 149: 5432-5439.
42. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000; 105: 1827-1832. (Pubitemid 30421764)
43. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996; 348: 159-161. (Pubitemid 26238099)
44. Munzberg H, Myers MG Jr: Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005; 8: 566-570. (Pubitemid 40594195)
45. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
46. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325-4328.
47. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709. (Pubitemid 32242624)
48. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M: Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145: 669-673.
49. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS: Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002; 8: 643-644. (Pubitemid 34778697)
50. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW: Absence of ghrelin protects against earlyonset obesity. J Clin Invest 2005; 115: 3573-3578. (Pubitemid 43121845)
51. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK: Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005; 115: 3564-3572. (Pubitemid 43121844)
52. van der Lely AJ, Tschop M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25: 426-457. (Pubitemid 38780667)
53. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-6325. (Pubitemid 351758344)
54. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL: Identification of the acyltransferase that octanoylates ghrelin, an appetitestimulating peptide hormone. Cell 2008; 132: 387-396. (Pubitemid 351192001)
55. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG: Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3: 379-386.
56. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-29. (Pubitemid 27298124)
57. Nogueiras R, Tovar S, Mitchell SE, Rayner DV, Archer ZA, Dieguez C, Williams LM: Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 2004; 53: 2552-2558. (Pubitemid 39299261)
58. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661. (Pubitemid 36262986)
59. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S: Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004; 145: 2607-2612. (Pubitemid 38686204)
60. Sakkou M, Wiedmer P, Anlag K, Hamm A, Seuntjens E, Ettwiller L, Tschop MH, Treier M: A role for brain-specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metab 2007; 5: 450-463. (Pubitemid 46825499)
61. Lage R, Vazquez MJ, Varela L, Saha AK, Vidal- Puig A, Nogueiras R, Dieguez C, Lopez M: Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 2010; 24: 2670-2679.
62. Nogueiras R, Lopez M, Lage R, Perez-Tilve D, Pfluger P, Mendieta-Zeron H, Sakkou M, Wiedmer P, Benoit SC, Datta R, Dong JZ, Culler M, Sleeman M, Vidal-Puig A, Horvath T, Treier M, Dieguez C, Tschop MH: Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology 2008; 149: 3009-3015. (Pubitemid 351724518)
63. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits M: Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via amp-activated protein kinase. J Biol Chem 2005; 280: 25196-25201. (Pubitemid 40934612)
64. Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschop MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao XB, Horvath TL, Diano S: UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008; 454: 846-851.
65. Velasquez DA, Martinez G, Romero A, Vazquez MJ, Boit KD, Dopeso-Reyes IG, Lopez M, Vidal A, Nogueiras R, Dieguez C: The central sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 2011; 60: 1177-1185.
66. Theander-Carrillo C, Wiedmer P, Cettour- Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schurmann A, Szanto I, Tschop MH, Rohner-Jeanrenaud F: Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006; 116: 1983-1993. (Pubitemid 44033322)
67. Sangiao-Alvarellos S, Vazquez MJ, Varela L, Nogueiras R, Saha AK, Cordido F, Lopez M, Dieguez C: Central ghrelin regulates peripheral lipid metabolism in a growth hormoneindependent fashion. Endocrinology 2009; 150: 4562-4574.
68. Davies JS, Kotokorpi P, Eccles SR, Barnes SK, Tokarczuk PF, Allen SK, Whitworth HS, Guschina IA, Evans BA, Mode A, Zigman JM, Wells T: Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol 2009; 23: 914-924.
69. Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N, Jorgensen JO: Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008; 57: 3205-3210.
70. Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, Grant E, Wilson-Perez HE, Granholm NA, Arnold M, Trevaskis JL, Butler AA, Davidson WS, Woods SC, Benoit SC, Sleeman MW, DiMarchi RD, Hui DY, Tschop MH: Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci;13: 877-882.
71. Cone RD: Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005; 8: 571-578. (Pubitemid 40594196)
72. Farooqi IS, O'Rahilly S: Genetic factors in human obesity. Obes Rev 2007; 8(Suppl 1): 37-40.
73. Song CK, Jackson RM, Harris RB, Richard D, Bartness TJ: Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1467-R1476. (Pubitemid 41507413)
74. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM, Howles PN, Morgan DA, Benoit SC, Szanto I, Schrott B, Schurmann A, Joost HG, Hammond C, Hui DY, Woods SC, Rahmouni K, Butler AA, Farooqi IS, O'Rahilly S, Rohner-Jeanrenaud F, Tschop MH: The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007; 117: 3475-3488. (Pubitemid 350097003)
75. Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ: Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007; 148: 5339-5347. (Pubitemid 350012626)
76. Shrestha YB, Vaughan CH, Smith BJ Jr, Song CK, Baro DJ, Bartness TJ: Central melanocortin stimulation increases phosphorylated perilipin A and hormone-sensitive lipase in adipose tissues. Am J Physiol Regul Integr Comp Physiol 2010; 299:R140-R149.
77. Albarado DC, McClaine J, Stephens JM, Mynatt RL, Ye J, Bannon AW, Richards WG, Butler AA: Impaired coordination of nutrient intake and substrate oxidation in melanocortin- 4 receptor knockout mice. Endocrinology 2004; 145: 243-252. (Pubitemid 38202165)
78. Li G, Zhang Y, Rodrigues E, Zheng D, Matheny M, Cheng KY, Scarpace PJ: Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss. Am J Physiol Endocrinol Metab 2007; 293:E252-E258. (Pubitemid 47105939)
79. Poritsanos NJ, Wong D, Vrontakis ME, Mizuno TM: Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin. Biochem Biophys Res Commun 2008; 376: 384-388.
80. Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD: Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes 2008; 57: 1482-1490.
81. Nogueiras R, Tschop MH, Zigman JM: Central nervous system regulation of energy metabolism: Ghrelin versus leptin. Ann NY Acad Sci 2008; 1126: 14-19. (Pubitemid 351589316)
82. Zigman JM, Elmquist JK: Minireview: From anorexia to obesity - the yin and yang of body weight control. Endocrinology 2003; 144: 3749-3756. (Pubitemid 37098305)